(19)
(11) EP 4 301 377 A1

(12)

(43) Date of publication:
10.01.2024 Bulletin 2024/02

(21) Application number: 21929368.5

(22) Date of filing: 01.03.2021
(51) International Patent Classification (IPC): 
A61K 31/785(2006.01)
A61P 13/12(2006.01)
A61K 31/74(2006.01)
C08F 226/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 13/12; C08F 226/02
 
C-Sets:
C08F 226/02, C08F 226/02;
(86) International application number:
PCT/US2021/020265
(87) International publication number:
WO 2022/186813 (09.09.2022 Gazette 2022/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Tricida Inc.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • KLAERNER, Gerrit
    San Francisco, California 94080 (US)
  • CONNOR, Eric F.
    San Francisco, California 94080 (US)
  • GBUR, Randi K.
    San Francisco, California 94080 (US)
  • KADE, Matthew J.
    San Francisco, California 94080 (US)
  • KIERSTEAD, Paul H.
    San Francisco, California 94080 (US)
  • BIYANI, Kalpesh N.
    San Francisco, California 94080 (US)
  • NGUYEN, Son H.
    San Francisco, California 94080 (US)
  • TABAKMAN, Scott M.
    San Francisco, California 94080 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) CROSSLINKED POLY(ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS